BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8464301)

  • 1. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
    Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
    Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis.
    Kohn S; Fradis M; Pratt H; Zidan J; Podoshin L; Robinson E; Nir I
    Laryngoscope; 1988 Aug; 98(8 Pt 1):865-71. PubMed ID: 3398664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
    Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW; Kaltenbach JA; Blakley BW; Burgio DL
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs.
    Teranishi M; Nakashima T; Wakabayashi T
    Hear Res; 2001 Jan; 151(1-2):61-70. PubMed ID: 11124452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
    Waissbluth S; Salehi P; He X; Daniel SJ
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
    Li Y; Ding D; Jiang H; Fu Y; Salvi R
    Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
    Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
    Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
    Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
    Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin ototoxicity and otoprotection with sodium salicylate.
    Hyppolito MA; de Oliveira JA; Rossato M
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):798-803. PubMed ID: 16758221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity.
    Minami SB; Sha SH; Schacht J
    Hear Res; 2004 Dec; 198(1-2):137-43. PubMed ID: 15567610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs.
    Baba M; Matsumoto Y; Kashio A; Cabral H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2012 Jan; 157(1):112-7. PubMed ID: 21807044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
    Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
    Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity.
    Fetoni AR; Sergi B; Ferraresi A; Paludetti G; Troiani D
    Acta Otolaryngol; 2004 May; 124(4):421-6. PubMed ID: 15224867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
    Fang B; Xiao H
    Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.